Part of the global pharmaceutical UBI Group, UBI Pharma consolidates the Group’s established values and builds a strong foundation of technology and production in the manufacture of pharmaceuticals, providing world-class pharmaceutical quality products. We develop innovative products such as non-monoclonal antibodies, novel small molecule drugs, and specialty injectables.
Learn more about our corporate governance, financial and investor information from the material information announcements posted on the Market Observation Post System.
Milestones in 2022
Milestones in 2021
Milestones in 2020
Milestones in 2019
Milestones in 2018
Milestones in 2017
Milestones in 2016
Milestones in 2015
Formosa Biomedical Technology Co., Ltd. joined and became an important strategic partner.
UBI Pharma obtained factory registration.